Profilo
Peter Ordentlich is the founder of Syndax Pharmaceuticals, Inc. since 2005, serving as Chief Scientific Officer.
Former positions include Principal at The Salk Institute for Biological Studies and Research Scientist at X-Ceptor Therapeutics, Inc. Education includes undergraduate and doctorate degrees from the University of Pennsylvania.
Posizioni attive di Peter Ordentlich
| Società | Posizione | Inizio |
|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Fondatore | 11/10/2005 |
Precedenti posizioni note di Peter Ordentlich
| Società | Posizione | Fine |
|---|---|---|
X-Ceptor Therapeutics, Inc.
X-Ceptor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development of small molecule therapeutics | Corporate Officer/Principal | - |
The Salk Institute for Biological Studies
The Salk Institute for Biological Studies Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formazione di Peter Ordentlich
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
The Salk Institute for Biological Studies
The Salk Institute for Biological Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
X-Ceptor Therapeutics, Inc.
X-Ceptor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development of small molecule therapeutics | Commercial Services |
















